SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-034330
Filing Date
2019-06-06
Accepted
2019-06-06 17:00:37
Documents
4
Period of Report
2019-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-11195_18k.htm 8-K 35285
2 EX-2.1 a19-11195_1ex2d1.htm EX-2.1 39066
3 EX-3.1 a19-11195_1ex3d1.htm EX-3.1 15070
4 EX-3.2 a19-11195_1ex3d2.htm EX-3.2 5174
  Complete submission text file 0001104659-19-034330.txt   96046
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Zyla Life Sciences (Filer) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36295 | Film No.: 19883198
SIC: 2834 Pharmaceutical Preparations